These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 8649650
21. Beneficial effect of neutrophil elastase inhibitor on anti-Thy1.1 nephritis in rats. Kumasaka R, Nakamura N, Fujita T, Murakami R, Shimada M, Osawa H, Yamabe H, Okumura K. Nephrology (Carlton); 2008 Feb; 13(1):27-32. PubMed ID: 18199098 [Abstract] [Full Text] [Related]
22. Single and multiple drug therapy in autologous immune complex nephritis in rats. Kupor LR, Lowance DC, McPhaul JJ. J Lab Clin Med; 1976 Jan; 87(1):27-36. PubMed ID: 128575 [Abstract] [Full Text] [Related]
24. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis. Omata M, Taniguchi H, Koya D, Kanasaki K, Sho R, Kato Y, Kojima R, Haneda M, Inomata N. J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498 [Abstract] [Full Text] [Related]
25. Contribution of ED-1- and CD-8-positive cells to the development of crescentic-type anti-GBM nephritis in rats. Hattori T, Nagamatsu T, Ito M, Suzuki Y. Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1228-39. PubMed ID: 7853754 [Abstract] [Full Text] [Related]
33. Therapeutic effect of all-trans-retinoic acid (at-RA) on an autoimmune nephritis experimental model: role of the VLA-4 integrin. Escribese MM, Conde E, Martín A, Sáenz-Morales D, Sancho D, Pérez de Lema G, Lucio-Cazaña J, Sánchez-Madrid F, García-Bermejo ML, Mampaso FM. BMC Nephrol; 2007 Jan 24; 8():3. PubMed ID: 17250768 [Abstract] [Full Text] [Related]
34. Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid. Greilich PE, Okada K, Latham P, Kumar RR, Jessen ME. Circulation; 2001 Sep 18; 104(12 Suppl 1):I265-9. PubMed ID: 11568067 [Abstract] [Full Text] [Related]
35. [Effects of reactive oxygen species scavenger and platelet activating factor receptor antagonist on accelerated nephrotoxic nephritis]. Kakuta S. Nihon Jinzo Gakkai Shi; 1993 Feb 18; 35(2):115-24. PubMed ID: 8315875 [Abstract] [Full Text] [Related]
36. [Pharmacological studies on experimental nephritic rats (13). The development and aggravation of nephritis due to the repeated administration of liquoid (author's transl)]. Ito M, Yokochi E, Kito T, Suzuki Y. Nihon Yakurigaku Zasshi; 1981 Apr 18; 77(4):419-25. PubMed ID: 6269971 [Abstract] [Full Text] [Related]
37. Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats. Leh S, Vaagnes Ø, Margolin SB, Iversen BM, Forslund T. Nephrol Dial Transplant; 2005 Jan 18; 20(1):71-82. PubMed ID: 15561744 [Abstract] [Full Text] [Related]
38. Chemical and histochemical studies of glomerular sialoprotein in nephrotoxic nephritis in rats. Chiu J, Drummond KN. Am J Pathol; 1972 Aug 18; 68(2):391-406. PubMed ID: 4114975 [Abstract] [Full Text] [Related]
39. [Production of reactive oxygen species and scavenger treatment in nephrotoxic nephritis]. Nakamura K. Nihon Jinzo Gakkai Shi; 1992 Jul 18; 34(7):761-72. PubMed ID: 1479715 [Abstract] [Full Text] [Related]
40. Antiproteinuric effect of pirfenidone in a rat model of anti-glomerular basement membrane glomerulonephritis. Takakura K, Mizukami K, Mitori H, Noto T, Tomura Y. Eur J Pharmacol; 2014 Aug 15; 737():106-16. PubMed ID: 24858365 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]